| | | | | | | | | | |
|
|
|
|
| Dockets Entered
On October 20, 2004
|
|
|
|
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
| 1999P-2630
|
| Establish a Daily Value for "added sugars"
|
|
|
|
|
| 1999P-5106
|
| Identify Sources of Natural Flavorings
|
|
|
|
|
| 2000P-1211
|
| Establish Mandatory Pre-Market Safety Testing for GE Foods
|
|
|
|
|
| 2001P-0075
|
| Switch Status of Emergency Contraceptives from Rx to OTC
|
|
|
|
|
| 2002P-0317
|
| Recall Aspartame as a Neurotoxic Drug
|
|
|
|
|
| 2003N-0076
|
| Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
|
|
|
|
|
| 2004D-0414
|
| FDA Review of Vaccine Labeling Requirements for Warnings, Use Instructions, and Precautionary Information
|
|
|
|
|
| 2004D-0431
|
| Draft Guidance for Industry: Current Good Manufacturing Practices for Combination Products
|
|
|
|
|
| 2004D-0440
|
| Guidance for Industry on Computerized Systems Used in Clinical Trials
|
|
|
|
|
| 2004D-0443
|
| Guidance for Industry on Quality Systems Approach to Pharmaceutical Current Good Manufacturing Regulations
|
|
|
|
|
| 2004N-0081
|
| BSE Risk Materials in Foods and Cosmetics
|
|
|
|
|
| 2004N-0267
|
| Applications for Approval to Market a New Drug; Complete Response Letter; Amendments to Unapproved Applications
|
|
|
|
|
| 2004P-0464
|
| Vitamin D and Calcium and Reduced Risk of Osteoporosis
|
|
|
|
|
| 1999P-2630
|
| Establish a Daily Value for "added sugars"
|
|
|
|
|
| EMC 799
|
| B. Combest
|
| Vol #:
|
| 33
|
|
|
|
|
| 1999P-5106
|
| Identify Sources of Natural Flavorings
|
|
|
|
|
| EMC 208
|
| D. Sellers
|
| Vol #:
|
| 3
|
|
|
|
|
| 2000P-1211
|
| Establish Mandatory Pre-Market Safety Testing for GE Foods
|
|
|
|
|
| C 12740
|
| Tammy Moppin
|
| Vol #:
|
| 789
|
|
|
|
|
| C 12741
|
| Athanasia Gregoriades
|
| Vol #:
|
| 789
|
|
|
|
|
| EMC 5839
|
| vnskar@aol.com
|
| Vol #:
|
| 789
|
|
|
|
|
| 2001P-0075
|
| Switch Status of Emergency Contraceptives from Rx to OTC
|
|
|
|
|
| EMC 10668
|
| K. Benitez
|
| Vol #:
|
| 294
|
|
|
|
|
| EMC 10669
|
| A. Snider
|
| Vol #:
|
| 294
|
|
|
|
|
| EMC 10670
|
| T. Quinn
|
| Vol #:
|
| 294
|
|
|
|
|
| EMC 10671
|
| A. Mantey
|
| Vol #:
|
| 294
|
|
|
|
|
| EMC 10672
|
| A. Boland
|
| Vol #:
|
| 294
|
|
|
|
|
| EMC 10673
|
| H. Drain
|
| Vol #:
|
| 294
|
|
|
|
|
| EMC 10674
|
| D. Thomas
|
| Vol #:
|
| 294
|
|
|
|
|
| EMC 10675
|
| L. Brognano
|
| Vol #:
|
| 294
|
|
|
|
|
| EMC 10676
|
| M. Leee
|
| Vol #:
|
| 294
|
|
|
|
|
| EMC 10677
|
| D. Thomas
|
| Vol #:
|
| 294
|
|
|
|
|
| EMC 10678
|
| R. Henry
|
| Vol #:
|
| 294
|
|
| | | | | | | | |
|
|
|
|
| EMC 10864
|
| K. McKnight
|
| Vol #:
|
| 294
|
|
|
|
|
| EMC 10865
|
| M. Hudson
|
| Vol #:
|
| 294
|
|
|
|
|
| EMC 10866
|
| K. Jackson
|
| Vol #:
|
| 294
|
|
|
|
|
| 2002P-0317
|
| Recall Aspartame as a Neurotoxic Drug
|
|
|
|
|
| EMC
379
|
| Calorie Control Council
|
| Vol #:
|
| 6
|
|
|
|
|
| EMC 380
|
| Dr. B. Martini
|
| Vol #:
|
| 6
|
|
|
|
|
| EMC 381
|
| Dr. B. Martini
|
| Vol #:
|
| 6
|
|
|
|
|
| EMC
382
|
| Calorie Control Council
|
| Vol #:
|
| 6
|
|
|
|
|
| 2003N-0076
|
| Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
|
|
|
|
|
| EMC 423
|
| A. Antonelli
|
| Vol #:
|
| 9
|
|
|
|
|
| EMC 424
|
| J. Hirsch
|
| Vol #:
|
| 9
|
|
|
|
|
| EMC 425
|
| V. Brimley
|
| Vol #:
|
| 9
|
|
|
|
|
| EMC 426
|
| R. Keller
|
| Vol #:
|
| 9
|
|
|
|
|
| EMC 427
|
| B and M Starks
|
| Vol #:
|
| 9
|
|
|
|
|
| EMC 428
|
| No signature
|
| Vol #:
|
| 9
|
|
|
|
|
| EMC 429
|
| No signature
|
| Vol #:
|
| 9
|
|
|
|
|
| EMC 430
|
| E. Pollard
|
| Vol #:
|
| 9
|
|
|
|
|
| EMC 431
|
| E. Pollard
|
| Vol #:
|
| 9
|
|
|
|
|
| EMC 432
|
| B. Coleman
|
| Vol #:
|
| 9
|
|
|
|
|
| EMC 433
|
| B. Coleman
|
| Vol #:
|
| 9
|
|
|
|
|
| EMC 434
|
| No signature
|
| Vol #:
|
| 9
|
|
|
|
|
| EMC 435
|
| H. Glynell
|
| Vol #:
|
| 9
|
|
|
|
|
| 2004D-0414
|
| FDA Review of Vaccine Labeling Requirements for Warnings, Use Instructions, and Precautionary Information
|
|
|
|
|
| EMC 1
|
| B. Sachau
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004D-0431
|
| Draft Guidance for Industry: Current Good Manufacturing Practices for Combination Products
|
|
|
|
|
| EMC 1
|
| B. Sachau
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004D-0440
|
| Guidance for Industry on Computerized Systems Used in Clinical Trials
|
|
|
|
|
| EMC 1
|
| B. Sachau
|
| Vol #:
|
| 1
|
|
|
|
|
| EMC 2
|
| B. Sachau
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004D-0443
|
| Guidance for Industry on Quality Systems Approach to Pharmaceutical Current Good Manufacturing Regulations
|
|
|
|
|
| EMC 1
|
| B. Sachau
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004N-0081
|
| BSE Risk Materials in Foods and Cosmetics
|
|
